micro-community-banner
Profile Image
  • Saved
Integrating Genetic Insights, Technological Advancements, Screening, and Personalized Pharmacological Interventions in Childhood Obesity - PubMed

Integrating Genetic Insights, Technological Advancements, Screening, and Personalized Pharmacological Interventions in Childhood Obesity - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39535684/

Childhood obesity is a significant global health challenge with rising prevalence over the past 50 years, affecting both immediate and long-term health outcomes. The increase in prevalence from 0.7% to...

Childhood obesity is a rising global epidemic influenced by genetics, genomics, and epigenetics. Advancements in genotyping enable personalized treatment and early screening, highlighting the importance of integrating genetics into clinical practice.

Profile Image
  • Saved
The impact of thyroid disorder on cardiovascular disease: Unraveling the connection and implications for patient care - PubMed

The impact of thyroid disorder on cardiovascular disease: Unraveling the connection and implications for patient care - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39507294/

The thyroid gland is responsible for metabolism, as well as cardiac function and the peripheral vascular system. Thyroid dysfunctions are associated with an increase in the risk of cardiovascular diseases,...

Thyroid dysfunctions increase cardiovascular disease risks, including heart failure, atrial fibrillation, and stroke. Amiodarone use can induce thyroid issues, requiring monitoring. Screening and treatment are essential for CVD patients' health outcomes.

Profile Image
  • Saved
Management of dyslipidemia in special groups - PubMed

Management of dyslipidemia in special groups - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38336098/

Dyslipidemia management in situations like pregnancy, in diseases like rheumatoid arthritis, human immunodeficiency virus (HIV) disease, chronic liver disease, and in the elderly are challenging scenarios. Pregnancy is a contraindication...

This manuscript discusses the challenges of managing dyslipidemia in pregnancy, rheumatoid arthritis, HIV, chronic liver disease, elderly patients, and COVID-19, highlighting unique treatment considerations and limited available data.

Profile Image
  • Saved
Weight Loss and Glycemic Control After Bariatric Surgery in Adolescents With Severe Obesity: A Randomized Controlled Trial - PubMed

Weight Loss and Glycemic Control After Bariatric Surgery in Adolescents With Severe Obesity: A Randomized Controlled Trial - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38069930/

Bariatric surgery was associated with substantial weight loss and improvements in glucose and lipid metabolism after 12 months compared to conservative treatment in adolescents with severe obesity.

Bariatric surgery led to significant weight loss and metabolic improvements in adolescents with severe obesity after failed lifestyle intervention, outperforming conservative treatment in a one-year randomized trial.

Profile Image
  • Saved
Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials - PubMed

Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38679221/

Semaglutide, a glucagon-like peptide-1 receptor agonist, has demonstrated clinically important weight loss effects in patients with type 2 diabetes. However, its effects on sustained weight loss in patients without diabetes...

Semaglutide (2.4 mg) significantly reduces body weight in overweight/obese individuals without diabetes, with a 12.1% relative weight loss. Gastrointestinal adverse events are common but mostly mild. Long-term efficacy and safety are confirmed.

Profile Image